Françoise Stanke-Labesque
INSERM U1042
Grenoble
F-38042 France
France
Name/email consistency: high
- Leukotriene B4 pathway activation and atherosclerosis in obstructive sleep apnea. Stanke-Labesque, F., Pépin, J.L., de Jouvencel, T., Arnaud, C., Baguet, J.P., Petri, M.H., Tamisier, R., Jourdil, J.F., Lévy, P., Bäck, M. J. Lipid Res. (2012)
- Ribavirin therapeutic drug monitoring: why, when and how? Stanke-Labesque, F., Loustaud-Ratti, V., Babany, G., Gagnieu, M.C., Marquet, P. Fundam. Clin. Pharmacol (2010)
- Increased urinary leukotriene E4 excretion in obstructive sleep apnea: effects of obesity and hypoxia. Stanke-Labesque, F., Bäck, M., Lefebvre, B., Tamisier, R., Baguet, J.P., Arnol, N., Lévy, P., Pépin, J.L. J. Allergy Clin. Immunol. (2009)
- Effect of dietary supplementation with increasing doses of docosahexaenoic acid on neutrophil lipid composition and leukotriene production in human healthy volunteers. Stanke-Labesque, F., Molière, P., Bessard, J., Laville, M., Véricel, E., Lagarde, M. Br. J. Nutr. (2008)
- Urinary leukotriene E4 excretion: a biomarker of inflammatory bowel disease activity. Stanke-Labesque, F., Pofelski, J., Moreau-Gaudry, A., Bessard, G., Bonaz, B. Inflamm. Bowel Dis. (2008)
- 2-Arachidonoyl glycerol induces contraction of isolated rat aorta: role of cyclooxygenase-derived products. Stanke-Labesque, F., Mallaret, M., Lefebvre, B., Hardy, G., Caron, F., Bessard, G. Cardiovasc. Res. (2004)